Patients who specifically want brand-name FDA-approved GLP-1 medications (oral Wegovy pill, injectable Wegovy, Zepbound, or Ozempic) through a telehealth platform Patients who specifically want a multi-condition membership platform (Hims covers hair loss, ED, mental health, etc.) rather than a focused GLP-1 program Patients with commercial insurance they want to run through pharmacy for brand-name GLP-1 coverage Patients who value Ros broader multi-condition telehealth catalog (sexual health, dermatology, fertility, etc.) under one platform Patients comfortable with a membership-plus-medication pricing model, where the total monthly cost is higher but medication variety is broader How to switch from Ro to Cora Health Patients who want to move their GLP-1 treatment from Ro to Cora Health can generally do so without clinical interruption, though the specific steps depend on medication, dose, and state
JAMA Oncology, 2025 (hazard ratio approximately 0.83 for overall cancer incidence)
Each peptide has unique properties, and the best choice depends on the goals of the research
Understanding this mechanism is essential for clinicians and patients to appropriately assess hypoglycemia risk and implement preventive strategies, particularly when tirzepatide is combined with other glucose-lowering medications